South Korea To Double Tamiflu Supply To Block Bird Flu
This article was originally published in PharmAsia News
Executive Summary
South Korea plans to double its Tamiflu (oseltamivir phosphate) stockpile by the end of this year, giving it 2.5 million doses of Roche's bird flu drug. The government estimates a supply that large could treat about 5 percent of the population. The administration made the decision at a Cabinet meeting that also cemented plans to establish a task force of several ministries to prevent an outbreak of bird flu. The plans were adopted in the wake of the country's first case of the avian influenza in April. (Click here for more
You may also be interested in...
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.